Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Cancer immunology immunotherapy"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Hu%2C+Yi%22&type=Person&filter%5B%5D=journalStr%3A%22Cancer+immunology+immunotherapy%22
/vufind/Search/Results?lookfor=%22Hu%2C+Yi%22&type=Person&filter%5B%5D=journalStr%3A%22Cancer+immunology+immunotherapy%22
Search /vufind/Search2/Results?lookfor=%22Hu%2C+Yi%22&type=Person&filter%5B%5D=journalStr%3A%22Cancer+immunology+immunotherapy%22
PubPharm (19)
1
IL13Rα2-targeted third-generation CAR-T cells with CD28 transmembrane domain mediate the best anti-glioblastoma efficacy
enthalten in:
Cancer immunology immunotherapy
| 2023
von
Gu, A.
|
Bai, Y.
|
Zhang, C.
| +6
Wird geladen...
2
IL13Rα2-targeted third-generation CAR-T cells with CD28 transmembrane domain mediate the best anti-glioblastoma efficacy
enthalten in:
Cancer immunology immunotherapy
| 2023
von
Gu, A.
|
Bai, Y.
|
Zhang, C.
| +6
Wird geladen...
3
Transient 40 °C-shock potentiates cytotoxic responses of $ Vδ2^{+} $ γδ T cell via HSP70 upregulation
enthalten in:
Cancer immunology immunotherapy
| 2022
von
Lin, L.
|
Chen, Y.
|
Chen, D.
| +4
Wird geladen...
4
Transient 40 °C-shock potentiates cytotoxic responses of $ Vδ2^{+} $ γδ T cell via HSP70 upregulation
enthalten in:
Cancer immunology immunotherapy
| 2022
von
Lin, L.
|
Chen, Y.
|
Chen, D.
| +4
Wird geladen...
5
Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world setting
enthalten in:
Cancer immunology immunotherapy
| 2021
von
Wu, Z.
|
Tao, H.
|
Zhang, S.
| +11
Wird geladen...
6
Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world setting
enthalten in:
Cancer immunology immunotherapy
| 2021
von
Wu, Z.
|
Tao, H.
|
Zhang, S.
| +11
Wird geladen...
7
Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world setting
enthalten in:
Cancer immunology immunotherapy
| 2021
von
Wu, Z.
|
Tao, H.
|
Zhang, S.
| +11
Wird geladen...
8
Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase
enthalten in:
Cancer immunology immunotherapy
| 2020
von
Xiong, Q.
|
Huang, Z.
|
Xin, L.
| +7
Wird geladen...
9
Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase
enthalten in:
Cancer immunology immunotherapy
| 2020
von
Xiong, Q.
|
Huang, Z.
|
Xin, L.
| +7
Wird geladen...
10
Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase
enthalten in:
Cancer immunology immunotherapy
| 2020
von
Xiong, Q.
|
Huang, Z.
|
Xin, L.
| +7
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Cancer immunology immunotherapy
Medienart
19
Aufsätze
12
E-Artikel
12
E-Ressourcen
7
Gedruckte Aufsätze
Zeitschriftentitel
Cancer immunology immunotherapy
Thema
9
Efficacy
9
Safety
6
Combination therapy
3
Anti-PD-1
3
Anti-PD-1/PD-L1 antibody
3
Biliary tract cancer
3
Breast cancer
3
Her-2
3
Immune checkpoint inhibitors
3
NLR
3
PARP inhibitors
3
PD-1 inhibitors
3
PLR
3
Pancreatic cancer
3
SCLC
3
SII
3
Th/Tr cells ratio
3
Treg cells
3
Tumors
3
VEGF
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
13
2020-
6
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
19
Englisch
Haven't found what you're looking for?
Wird geladen...